NCT06238960 Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.
| NCT ID | NCT06238960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Total Hip Replacement |
| Study Type | INTERVENTIONAL |
| Enrollment | 104 participants |
| Start Date | 2024-02-10 |
| Primary Completion | 2026-11-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 104 participants in total. It began in 2024-02-10 with a primary completion date of 2026-11-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total arthroplasty (THA) is the treatment of choice for severe osteoarthritis of the hip joint. Following this type of intervention, a multidisciplinary rehabilitation approach allows you to reduce pain and improve the ability to carry out activities of daily living (ADL), but it is not clear what the optimal rehabilitation program is. Recently, the use of telerehabilitation has increased over the years. Specifically, in treatment of patients following THA surgery, telerehabilitation is able to give similar results to the treatment performed in person terms of pain and function. The aim of this study is to verify whether telerehabilitation associated with In-person treatment is comparable in terms of pain, recovery functionality and patient participation and satisfaction, compared to those provided by rehabilitation alone in the presence of patients undergoing THA surgery.
Eligibility Criteria
Inclusion Criteria: * Having undergone total hip replacement surgery (THA) * Start outpatient treatment within 7 days of discharge from the Orthopedic Department * Age between 50 and 80 years. * Continuation of rehabilitation treatments at the IOR Physical Medicine and Rehabilitation service in Argenta. * The subjects or any caregivers must be able to use an electronic device (PC, tablet, smartphone). Exclusion Criteria: * patients undergoing revision of previous prosthesis surgery * difficulty understanding the Italian language/language barrier * unavailability stable wi-fi connection by the patient
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06238960 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Total Hip Replacement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06238960 currently recruiting?
Yes, NCT06238960 is actively recruiting participants. Contact the research team at marco.ruggiero@ior.it for enrollment information.
Where is the NCT06238960 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06238960 clinical trial?
NCT06238960 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 104 participants.